A: Adherence to timelines
Efficient project management to deliver projects within the stipulated time.
Founded by two eminent researchers with one conviction: quality generics are a must, not an option.
About us
BioRadius Therapeutic Research is a research-driven company, founded in 2018 by two eminent researchers on the principle that quality generics are a must, not an option. Since its inception, BioRadius has completed more than 130 studies and filed them with international regulatory agencies including the USFDA and EMA.
We support pharmaceutical, biotech and medical device companies with clinical trials, bioequivalence studies, bioanalytical services, monitoring and product characterization, helping with cost containment, revenue growth and faster market reach. We align our services to help clients navigate regulatory pathways efficiently and shorten the clinical trial lifecycle, without compromising on quality.
It's in our DNA
Founded to deliver excellence in bioequivalence, BioRadius's DNA is made of these four bases.
Efficient project management to deliver projects within the stipulated time.
Inspected and audited by third-party and sponsor QA teams. Inspected by the USFDA with zero observations: zero 483s.
Every project is carried out following all applicable guidelines.
Reach out to see how competitive we are, in both quality and cost.
Only the best
No compromise on quality. Pilot or pivotal, our eye for quality stays the same on every project.
We understand how much timelines matter; sometimes they make all the difference. We don't sign a project unless we foresee finishing it within the stipulated timeline.
We serve small and medium-sized international and national pharma companies with custom-tailored, cost-effective solutions that move products to market.
Our vision
In classical geometry, a radius is a line segment that starts at the centre and reaches out to the edge of the circle. In the same way, BioRadius was founded to sit at the centre of pharma research while extending its reach to any point in the healthcare industry.
Our vision is to be a substantial stakeholder in the pharmaceutical industry, bringing drugs and devices to patients of every economic stratum efficiently, cost-effectively and on time.
Towards this vision, BioRadius Therapeutic Research provides custom-tailored, cost-effective bioequivalence research to generic pharmaceutical companies, to promote quality, affordable medicines.
Leadership
Research professionals with high-level experience at esteemed international organizations.
Let's bring it to the market together. Tell us about your product and timelines, and we'll come back with a plan and a quote.